STEM-28. NANOPARTICLES ENCAPSULATING A CONNEXIN43 MIMETIC PEPTIDE LIMIT GLIOMA STEM CELL SURVIVAL AND GLIOBLASTOMA PROGRESSION

Glioblastoma (GBM) is the most common and aggressive primary adult brain tumor in the US. The current treatment regimen for GBM still retains an alarmingly poor prognosis, with median survival of only 14.6 months. Failure to generate more effective treatment strategies is due to the infiltrative nat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neuro Oncol
Glavni autori: Will, John, Thompson, Emily, Harrigan, Megan, Smyth, James, Sheng, Zhi, Gourdie, Robert, Sontheimer, Harry, Foster, Johan, Lamouille, Samy
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Cancer Stem Cells
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651682/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.845
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items